Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 740, pseudogene (RNU6-740P) is a non-coding sequence derived from the U6 snRNA gene, annotated as the 740th variant in a given genome. Like other U6 snRNA pseudogenes, it likely arose via retrotransposition, resulting in a DNA sequence with high similarity to functional U6 snRNA but lacking essential regulatory or coding sequences required for function. Pseudogenes such as RNU6-740P may occasionally be transcribed, and in rare instances contribute to regulatory RNA networks (through mechanisms like ceRNA or RNAi), but most are considered genomically inert "processed pseudogenes" with no direct biological role. The parental gene, U6 snRNA, is a core component of the spliceosome, essential for mRNA splicing; however, the pseudogene variant does not contribute to this process.
None relevant. Drugs do not act on this pseudogene itself. Any theoretical regulatory functions would be indirect (e.g., via regulatory RNA networks), but are not established for this specific pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 740, pseudogene (RNU6-740P).